TABLE 2.
PFGE major pulsotype (n, %)a | PFGE subtype | No.c (%) of isolates from hospitald:
|
||||||
---|---|---|---|---|---|---|---|---|
HT (53) | H1 (18) | H2 (8) | H3 (12) | H4 (8) | H5 (4, 7) | H6 (3) | ||
A (20, 38) | A1 | 10 (19) | 2 (11) | 1* (12.5) | 4 (33) | 2 (25) | 1 (25, 100) | |
A2 | 1 (2) | 1 (6) | ||||||
A3 | 2 (4) | 2 (11) | ||||||
A4 | 1 (2) | 1 (6) | ||||||
A5 | 1 (2) | 1 (6) | ||||||
A6 | 1 (2) | 1 (6) | ||||||
A7 | 2 (4) | 2 (25) | ||||||
A8 | 1 (2) | 1 (25) | ||||||
A9 | 1 (2) | 1 (12.5) | ||||||
B (18, 34) | B1 | 11 (21) | 3 (17) | 1* (25) | 1 (8) | 2 (50) | 3 (100) | |
B2 | 5 (9) | 4 (22) | 1 (2.5) | |||||
B3 | 1 (2) | 1 (8) | ||||||
B4 | 1 (2) | 1 (6) |
Data in boldface are for MRSA isolates involved in an outbreak that occurred August to September 1999.
n, number of isolates obtained from May to July 1999.
Asterisks indicate community-acquired infections.
HT, all hospitals. Total numbers of isolates from hospitals are in parentheses.